SciELO - Scientific Electronic Library Online

vol.12 issue4VA-MENGOC-BC® efficacy evaluation in Balb/c mice challenged with serogroups A, B and C author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO



Print version ISSN 1025-028XOn-line version ISSN 1025-0298


RUIZ, Nancy M; ALVAREZ, Giselle  and  NOA, Enrique. Procedures for obtaining the biological reagents for the DAVIH Ag P24 and DAVIH Ac P24 kits. Vaccimonitor [online]. 2003, vol.12, n.4, pp.16-23. ISSN 1025-028X.

AIDS epidemic is one of the most serious problems affecting humanity today. Since science, despite all the great efforts made by scientists throughout the world, has not been able to find an effective vaccine to cure this disease, the use of anti-retroviral drugs has given the most successful results in improving life quality of AIDS patients. Hence, the importance of having the means to carry out an early diagnosis of the infection, as well as monitoring its progression with the purpose of having an influence on it. The present research work describes the obtaining of biological components required for the production of two kits used in Cuba for all HIV-AIDS related studies. To achieve this, a protocol was made that included different stages in the purification and immobilization of several molecules. Monoclonal antibody anti p24, HIV-1 p24, and polyclonal human antibodies anti p24 were obtained, with an adequate level of purity and biological activity allowing its use as intermediate products in the above mentioned stages and as reagents comprised in the kits.

Keywords : purification; monoclonal antibodies; immobilization; p24; HIV-1; polyclonal human antibodies.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License